Latest University of California, San Francisco Stories
WASHINGTON, April 9, 2014 /PRNewswire-USNewswire/ -- Congressman Chaka Fattah (D-PA), a Senior Member on the House Appropriations Committee and architect of the Fattah Neuroscience Initiative,
In an innovative clinical trial led by UC San Francisco, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer.
Chemists in The College of Arts and Sciences have, for the first time, created enzyme-like activity using peptides that are only seven amino acids long.
Michael Johns III, MD, Associate Professor of Otolaryngology and Director, Emory Voice Center, Emory University, School of Medicine, Atlanta, GA, presented on The Aging Voice and Reinnervation
Claire M. Brett, MD, Professor of Anesthesiology and Pediatrics, University of California, San Francisco, School of Medicine, presented on Care of the Formerly Premature Pediatric Patient.
SAN FRANCISCO, March 10, 2014 /PRNewswire/ -- Alector, LLC announced today a collaborative research agreement facilitated by the Johnson & Johnson Innovation Center in California.
Joint Gladstone-UCSF study highlights novel reprogramming method; offers new hope for treating liver failure.
Adoption of new guidelines recommending screening mammography every two years for women ages 50 to 74 would result in breast cancer screening that is equally effective, while saving the United States $4.3 billion a year in health care costs, according to a study led by UC San Francisco.
A new analysis of animal studies on cholesterol-lowering statins by UC San Francisco researchers found that non-industry studies had results that favored the drugs even more than studies funded by industry.
- totally perplexed and mixed up.